East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. Aurobindo Pharma’s Adapalene and Benzoyl Peroxide Topical Gel, are an AB-rated generic equivalent to the reference listed drug (RLD), Epiduo® Forte Topical Gel, manufactured by […] The post Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% appeared first on Aurobindo Pharma USA .